UPDATE — Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th
Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ETNEW YORK, NY, June 06, 2022 (GLOBE NEWSWIRE) --...
Month: June 2022
SAB Biotherapeutics Announces Appointment of Alexandra Kropotova, M.D., as Chief Medical Officer
SIOUX FALLS, S.D., June 06, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a...
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
-- Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest...
ChemoCentryx Reports Safety Results Available from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
-- Consistent with approved antibody inhibitors of PD-L1, CCX559 demonstrates immunomodulatory activity in first cycle of treatment -- -- Safety...
WIMI Hologram Academy: The Application of AR in Education and Its Prospects
HONG KONG, June 06, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
Treosulfan Pivotal Study Results Published
Study’s primary endpoint and key secondary endpoints were met Study found event-free survival and overall survival superior after treosulfan compared...
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
WARREN, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve...
Amarin Appoints Tom Reilly as New Chief Financial Officer
-- Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin -- -- Michael W. Kalb to...
iCAD to Present at the JMP Securities Life Sciences Conference on June 15-16, 2022
NASHUA, N.H., June 06, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer...
Piezo Motion Launches High-Precision, Standing Wave-Type Line of Motors Ahead of the Energy, Drone & Robotics Summit
Piezo Motion’s new rotary motors provide superior performance for next-generation drones and satellitesLAKEWOOD RANCH, Fla., June 06, 2022 (GLOBE NEWSWIRE)...
Xalud Therapeutics CEO to Participate in Two Gene Therapy Focused Panels at BIO International Convention 2022
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to...
EDAP Announces Multiple Oral Presentations at the 21st International Symposium on Therapeutic Ultrasound
LYON, France, June 6, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
AltruBio to Present at the 2022 BIO International Convention
Judy Chou, Ph.D. President and CEOSAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a...
Jasper Therapeutics Announces Annual Virtual Stockholders Meeting to be Held on Thursday, June 23, 2022
REDWOOD CITY, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic...
Madrigal Pharmaceuticals Supports International NASH Day on June 9
Company expands its partnerships with leading patient advocacy groups to improve NASH education and patient careCONSHOHOCKEN, Pa., June 06, 2022...
Novartis Tafinlar® (dabrafenib) + Mekinist® (trametinib) demonstrates unprecedented efficacy in pediatric patients with BRAF V600 low-grade gliomas in Phase II/III study
Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and reduced risk of progression or...
IO Biotech to Participate in the 2022 BIO International Convention
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
Portage Biotech Summarizes Data Presented at ASCO 2022 Annual Meeting Including Updates from Ongoing PORT-2 Study
Preliminary data from the Phase 1/2 trial of PORT-2 demonstrates favorable safety and tolerability as a monotherapy with translational data...
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
MINNEAPOLIS, June 06, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Assembly Biosciences Initiates Phase 1b Clinical Trial Evaluating Next Generation Core Inhibitor ABI-H3733 for the Treatment of Chronic Hepatitis B Virus Infection
SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...